Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation

Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation

Background/AimsThe most commonly used immunosuppressant therapy after liver transplantation (LT) is a combination of tacrolimus and steroid. Basiliximab induction has recently been introduced; however, the most appropriate immunosuppression for hepatocellular carcinoma (HCC) patients after LT is sti...

Full description

Bibliographic Details
Main Authors: Ju-Yeun Lee, Yul Hee Kim, Nam-Joon Yi, Hyang Sook Kim, Hye Suk Lee, Byung Koo Lee, Hyeyoung Kim, Young Rok Choi, Geun Hong, Kwang-Woong Lee, Kyung-Suk Suh
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2014-06-01
Series:Clinical and Molecular Hepatology
Subjects:
Immunosuppression
Basiliximab
Microvascular invasion
PIVKA-II
AFP
F-PET scan
Online Access:http://e-cmh.org/upload/pdf/cmh-20-192.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-20-192.pdf

Similar Items